BridgeBio Oncology Therapeutics, Inc.
BBOT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001869105
No open-market purchases or sales by BridgeBio Oncology Therapeutics, Inc. insiders were filed in the last 90 days; 65 institutions reported holding it in 13F filings for Q2 2026, worth $450.6M in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in BridgeBio Oncology Therapeutics, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 32
- +2 vs. Q3 2024
- Shares held
- 16.4M
- +371.8K (+2.3%) vs. Q3 2024
- Total value
- $172.7M
- +$4.71M (+2.8%) vs. Q3 2024
- New holders
- 5
- 7 more added
- Sold out
- 3
- 3 more reduced
1 institution that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BBOT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 65 | $450.6M |
| Q1 2026 | 67 | $513.8M |
| Q4 2025 | 52 | $724.7M |
| Q3 2025 | 42 | $657.5M |
| Q2 2025 | 34 | $177.6M |
| Q1 2025 | 31 | $186.3M |
| Q4 2024 | 32 | $172.7M |
| Q3 2024 | 31 | $171.1M |
| Q2 2024 | 31 | $167.4M |
| Q1 2024 | 29 | $166.9M |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding BridgeBio Oncology Therapeutics, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Tower Research Capital LLC (TRC) | 1 | $10 | 0.00% | +1 | New |
| Geode Capital Management, LLC | 13,274 | $139.4K | 0.00% | +2,405+22.1% | Added |
| Gritstone Asset Management LLC | 24,666 | $259.0K | 0.27% | +24,666 | New |
| UBS Group AG | 34,948 | $367.0K | 0.00% | +34,927+166,319.0% | Added |
| Toronto Dominion Bank | 49,500 | $519.8K | 0.00% | +49,500 | New |
| Moore Capital Management, LP | 100,000 | $1.05M | 0.02% | 00.0% | Unchanged |
| Woodline Partners LP | 103,247 | $1.08M | 0.01% | 00.0% | Unchanged |
| TD Asset Management Inc | 144,772 | $1.52M | 0.00% | 00.0% | Unchanged |
| Acuta Capital Partners, LLC | 180,945 | $1.90M | 1.91% | 00.0% | Unchanged |
| Wellington Management Group LLP | 184,590 | $1.94M | 0.00% | −800.0% | Reduced |
| Decagon Asset Management LLP | 186,454 | $1.96M | 0.89% | +186,454 | New |
| Two Sigma Investments, LP | 189,285 | $1.99M | 0.00% | 00.0% | Unchanged |
| StemPoint Capital LP | 200,900 | $2.11M | 0.53% | +900+0.4% | Added |
| Affinity Asset Advisors, LLC | 250,000 | $2.63M | 0.41% | 00.0% | Unchanged |
| Octagon Capital Advisors LP | 250,000 | $2.63M | 0.45% | 00.0% | Unchanged |
| Harraden Circle Investments, LLC | 257,226 | $2.70M | 2.15% | +257,226 | New |
| Laurion Capital Management LP | 300,000 | $3.15M | 0.20% | 00.0% | Unchanged |
| T. Rowe Price Investment Management, Inc. | 400,247 | $4.20M | 0.00% | +2,598+0.7% | Added |
| ADAR1 Capital Management, LLC | 404,138 | $4.24M | 0.87% | 00.0% | Unchanged |
| Soros Fund Management LLCSuperinvestorSoros Fund Management | 475,114 | $4.99M | 0.09% | +1140.0% | Added |
| Perceptive Advisors LLC | 500,000 | $5.25M | 0.15% | 00.0% | Unchanged |
| Great Point Partners LLC | 500,000 | $5.25M | 2.47% | 00.0% | Unchanged |
| Commodore Capital LP | 500,000 | $5.25M | 0.38% | 00.0% | Unchanged |
| Silverarc Capital Management, LLC | 513,369 | $5.39M | 1.21% | 00.0% | Unchanged |
| Farallon Capital Management, L.L.C. | 600,000 | $6.30M | 0.03% | 00.0% | Unchanged |
| Sculptor Capital LP | 705,000 | $7.40M | 0.12% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 1,087,771 | $11.4M | 0.00% | −39,827−3.5% | Reduced |
| Millennium Management LLC | 1,142,302 | $12.0M | 0.01% | +11,985+1.1% | Added |
| Citadel Advisors LLC | 1,339,670 | $14.1M | 0.01% | +7,020+0.5% | Added |
| Adage Capital Partners GP, L.L.C. | 1,400,000 | $14.7M | 0.03% | 00.0% | Unchanged |
| BlackRock, Inc. | 1,498,865 | $15.7M | 0.00% | −1,135−0.1% | Reduced |
| Cormorant Asset Management, LP | 2,909,000 | $30.5M | 1.68% | 00.0% | Unchanged |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −119,880−100.0% | Sold out |
| Cowen and Company, LLC | 0 | $0 | 0.00% | −45,048−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| Ghost Tree Capital, LLC | – | – | – | – | Not filed |